fig2

Figure 2. Plots comparing CTC populations between patients with localised (Cohort A) and advanced disease (Cohort B). CTCs from 20 mL of blood were pre-enriched using the Parsortix^TM microfluidic system and enumerated by DEParray^TM after immunostaining. CTCs were isolated from mesenchymal (Vim) and epithelial (Pan CK) biomarkers. (A) Vim⁺ CK⁺ CTCs; (B) Vim^- CK⁺ CTCs; (C) Vim⁺ CK^- CTCs; (D) Total CTCs. All CTCs were CD45^-. CTCs: Circulating tumour cells; Vim: vimentin; CK: cytokeratin.